PortfoliosLab logoPortfoliosLab logo
RAPT vs. PAVE
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

RAPT vs. PAVE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in RAPT Therapeutics, Inc. (RAPT) and Global X US Infrastructure Development ETF (PAVE). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

RAPT vs. PAVE - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
RAPT
RAPT Therapeutics, Inc.
71.30%167.96%-93.64%25.51%-46.09%85.97%-28.47%112.38%
PAVE
Global X US Infrastructure Development ETF
6.32%19.36%17.92%31.01%-7.17%36.42%19.72%7.74%

Returns By Period

In the year-to-date period, RAPT achieves a 71.30% return, which is significantly higher than PAVE's 6.32% return.


RAPT

1D
0.00%
1M
0.07%
YTD
71.30%
6M
124.97%
1Y
494.47%
3Y*
-38.25%
5Y*
-15.58%
10Y*

PAVE

1D
3.29%
1M
-7.77%
YTD
6.32%
6M
7.40%
1Y
35.92%
3Y*
22.36%
5Y*
15.85%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

RAPT vs. PAVE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RAPT
RAPT Risk / Return Rank: 9898
Overall Rank
RAPT Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
RAPT Sortino Ratio Rank: 9898
Sortino Ratio Rank
RAPT Omega Ratio Rank: 9797
Omega Ratio Rank
RAPT Calmar Ratio Rank: 9999
Calmar Ratio Rank
RAPT Martin Ratio Rank: 9898
Martin Ratio Rank

PAVE
PAVE Risk / Return Rank: 8787
Overall Rank
PAVE Sharpe Ratio Rank: 8484
Sharpe Ratio Rank
PAVE Sortino Ratio Rank: 8787
Sortino Ratio Rank
PAVE Omega Ratio Rank: 8282
Omega Ratio Rank
PAVE Calmar Ratio Rank: 9090
Calmar Ratio Rank
PAVE Martin Ratio Rank: 8989
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RAPT vs. PAVE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for RAPT Therapeutics, Inc. (RAPT) and Global X US Infrastructure Development ETF (PAVE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


RAPTPAVEDifference

Sharpe ratio

Return per unit of total volatility

4.73

1.61

+3.12

Sortino ratio

Return per unit of downside risk

4.47

2.30

+2.17

Omega ratio

Gain probability vs. loss probability

1.59

1.31

+0.28

Calmar ratio

Return relative to maximum drawdown

11.35

2.90

+8.45

Martin ratio

Return relative to average drawdown

25.83

10.73

+15.10

RAPT vs. PAVE - Sharpe Ratio Comparison

The current RAPT Sharpe Ratio is 4.73, which is higher than the PAVE Sharpe Ratio of 1.61. The chart below compares the historical Sharpe Ratios of RAPT and PAVE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


RAPTPAVEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

4.73

1.61

+3.12

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.13

0.74

-0.87

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.07

0.63

-0.70

Correlation

The correlation between RAPT and PAVE is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

RAPT vs. PAVE - Dividend Comparison

RAPT has not paid dividends to shareholders, while PAVE's dividend yield for the trailing twelve months is around 0.86%.


TTM202520242023202220212020201920182017
RAPT
RAPT Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PAVE
Global X US Infrastructure Development ETF
0.86%0.92%0.54%0.68%0.84%0.48%0.44%0.67%0.78%0.30%

Drawdowns

RAPT vs. PAVE - Drawdown Comparison

The maximum RAPT drawdown since its inception was -98.47%, which is greater than PAVE's maximum drawdown of -44.08%. Use the drawdown chart below to compare losses from any high point for RAPT and PAVE.


Loading graphics...

Drawdown Indicators


RAPTPAVEDifference

Max Drawdown

Largest peak-to-trough decline

-98.47%

-44.08%

-54.39%

Max Drawdown (1Y)

Largest decline over 1 year

-36.08%

-12.56%

-23.52%

Max Drawdown (5Y)

Largest decline over 5 years

-98.14%

-26.23%

-71.91%

Current Drawdown

Current decline from peak

-85.16%

-8.70%

-76.46%

Average Drawdown

Average peak-to-trough decline

-63.85%

-6.30%

-57.55%

Ulcer Index

Depth and duration of drawdowns from previous peaks

22.87%

3.39%

+19.48%

Volatility

RAPT vs. PAVE - Volatility Comparison

The current volatility for RAPT Therapeutics, Inc. (RAPT) is 0.51%, while Global X US Infrastructure Development ETF (PAVE) has a volatility of 7.74%. This indicates that RAPT experiences smaller price fluctuations and is considered to be less risky than PAVE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


RAPTPAVEDifference

Volatility (1M)

Calculated over the trailing 1-month period

0.51%

7.74%

-7.23%

Volatility (6M)

Calculated over the trailing 6-month period

69.27%

13.97%

+55.30%

Volatility (1Y)

Calculated over the trailing 1-year period

119.45%

22.40%

+97.05%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

123.30%

21.42%

+101.88%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

124.92%

24.41%

+100.51%